title: Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30.
authors.affiliation: Department of Nuclear Medicine, University Hospital of Leipzig, Liebigstraße 18, 04109, Leipzig, Germany. regine.kluge@medizin.uni-leipzig.de.
authors.forename: Regine
authors.identifier: http://orcid.org/0000-0003-1245-1290
authors.initials: R
authors.lastname: Kluge
authors.affiliation: Department of Nuclear Medicine, University Hospital of Leipzig, Liebigstraße 18, 04109, Leipzig, Germany.
authors.forename: Lars
authors.initials: L
authors.lastname: Kurch
authors.affiliation: Department of Nuclear Medicine, University Hospital of Leipzig, Liebigstraße 18, 04109, Leipzig, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Georgi
authors.affiliation: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16-18, 04107, Leipzig, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Hasenclever
mesh_terms: D000293:Adolescent; D002648:Child; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000378:metabolism*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000378:metabolism; D010257:Paraneoplastic Syndromes / Q000000981:diagnostic imaging* / Q000378:metabolism*; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods
chemical_list: D019788:Fluorodeoxyglucose F18